]> M-8000-9136,9141-9582,9700-9701 C42.0 Blood C42.1 Bone marrow C42.2 Spleen C42.3 Reticuloendothelial system, NOS C42.4 Hematopoietic system, NOS C76.0 Head, face or neck, NOS C76.1 Thorax, NOS C76.2 Abdomen, NOS C76.3 Pelvis, NOS C76.4 Upper limb, NOS C76.5 Lower limb, NOS C76.7 Other ill-defined sites C76.8 Overlapping lesion of ill-defined sites C77.0 Lymph nodes of head, face and neck C77.1 Lymph nodes of intrathoracic C77.2 Lymph nodes of intra-abdominal C77.3 Lymph nodes of axilla or arm C77.4 Lymph nodes of inguinal region or leg C77.5 Lymph nodes of pelvis C77.8 Lymph nodes of multiple regions C77.9 Lymph nodes, NOS C80.9 Unknown primary site Note 1: AJCC does not define TNM staging for these sites. Note 2: Excludes hematopoietic, reticuloendothelial, immunoproliferative and myeloproliferative neoplasms, Hodgkin and non-Hodgkin lymphomas, and Kaposi sarcoma. &generalsize; ¬appextension; ¬appcsextevalnontnm; ¬applymphnodes; ¬appcsregnodesevalnontnm; ¬appreglnpos; ¬appreglnexam; ¬appcsmetsatdx; ¬appcsmetsevalnontnm; ¬appssfactor1; ¬appssfactor2; ¬appssfactor3; ¬appssfactor4; ¬appssfactor5; ¬appssfactor6; ¬appnewssf7; ¬appnewssf8; ¬appnewssf9; ¬appnewssf10; ¬appnewssf11; ¬appnewssf12; ¬appnewssf13; ¬appnewssf14; ¬appnewssf15; ¬appnewssf16; ¬appnewssf17; ¬appnewssf18; ¬appnewssf19; ¬appnewssf20; ¬appnewssf21; ¬appnewssf22; ¬appnewssf23; ¬appnewssf24; ¬appnewssf25; ¬apphistologiestnm7; ¬appajcchistologies; ¬appcsstagetnm7; ¬appcsstage; &commonsummarystage;